Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer and Metastasis Reviews
Published in: Cancer and Metastasis Reviews 4/2016

01-12-2016

Cancer-derived extracellular vesicles: the ‘soil conditioner’ in breast cancer metastasis?

Authors: Andrew R. Chin, Shizhen Emily Wang

Published in: Cancer and Metastasis Reviews | Issue 4/2016

Login to get access

Abstract

It has been recognized that cancer-associated mortality is more often a result of the disrupted physiological functions in multiple organs following metastatic dissemination of cancer cells, rather than the presence and growth of the primary tumor. Despite advances in our understanding of the events leading to cancer initiation, growth, and acquisition of invasive properties, we are still unable to effectively treat metastatic disease. It is now being accepted that the secretion of extracellular vesicles, such as exosomes from cancer cells, has a profound impact on the initiation and propagation of metastatic breast cancer. These cancer-secreted vesicles differ from other means of cellular communication due to their capability of bulk delivery and organotropism. Here, we provide an overview of the role of extracellular vesicles in breast cancer metastasis and discuss key areas that may facilitate our understanding of metastatic breast cancer to guide our efforts towards providing better therapies.
Literature
1.
2.
3.
4.
McCready, J., Sims, J. D., et al. (2010). Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer , 10, 294.CrossRefPubMedPubMedCentral
5.
Melo, S. A., Sugimoto, H., et al. (2014). Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell , 26(5), 707–721.CrossRefPubMedPubMedCentral
6.
O'Brien, K., Rani, S., et al. (2013). Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. European Journal of Cancer , 49(8), 1845–1859.CrossRefPubMed
7.
8.
Le, M. T., Hamar, P., et al. (2014). miR-200-containing extracellular vesicles promote breast cancer cell metastasis. The Journal of Clinical Investigation , 124(12), 5109–5128.CrossRefPubMedPubMedCentral
9.
Smith, Z. J., Lee, C., et al. (2015). Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content. J Extracell Vesicles , 4, 28533.CrossRefPubMed
10.
Su, J. (2015). Label-free single molecule detection using Microtoroid optical resonators. Journal of Visualized Experiments , 106, e53180.
11.
Tauro, B. J., Greening, D. W., et al. (2013a). Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Molecular & Cellular Proteomics , 12(3), 587–598.CrossRef
12.
Willms, E., Johansson, H. J., et al. (2016). Cells release subpopulations of exosomes with distinct molecular and biological properties. Scientific Reports , 6, 22519.CrossRefPubMedPubMedCentral
13.
Koumangoye, R. B., Sakwe, A. M., et al. (2011). Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PloS One , 6(9), e24234.CrossRefPubMedPubMedCentral
14.
15.
Hoshino, D., Kirkbride, K. C., et al. (2013). Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Reports , 5(5), 1159–1168.CrossRefPubMed
16.
Purushothaman, A., Bandari, S. K., et al. (2016). Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions. The Journal of Biological Chemistry , 291(4), 1652–1663.CrossRefPubMed
17.
Cho, J. A., Park, H., et al. (2012). Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. International Journal of Oncology , 40(1), 130–138.PubMed
18.
Luga, V., Zhang, L., et al. (2012). Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell , 151(7), 1542–1556.CrossRefPubMed
19.
Dutta, S., Warshall, C., et al. (2014). Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PloS One , 9(5), e97580.CrossRefPubMedPubMedCentral
20.
Yang, M., Chen, J., et al. (2011). Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Molecular Cancer , 10, 117.CrossRefPubMedPubMedCentral
21.
Seubert, B., Grunwald, B., et al. (2015). Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology , 61(1), 238–248.CrossRefPubMed
22.
Skog, J., Wurdinger, T., et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nature Cell Biology , 10(12), 1470–1476.CrossRefPubMedPubMedCentral
23.
Jung, K. K., Liu, X. W., et al. (2006). Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. The EMBO Journal , 25(17), 3934–3942.CrossRefPubMedPubMedCentral
24.
Zhou, W., Fong, M. Y., et al. (2014). Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell , 25(4), 501–515.CrossRefPubMedPubMedCentral
25.
Tominaga, N., Kosaka, N., et al. (2015). Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nature Communications , 6, 6716.CrossRefPubMedPubMedCentral
26.
Fong, M. Y., Zhou, W., et al. (2015). Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nature Cell Biology , 17(2), 183–194.CrossRefPubMedPubMedCentral
27.
Zhang, L., Zhang, S., et al. (2015). Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature , 527(7576), 100–104.CrossRefPubMedPubMedCentral
28.
Xiang, X., Poliakov, A., et al. (2009). Induction of myeloid-derived suppressor cells by tumor exosomes. International Journal of Cancer , 124(11), 2621–2633.CrossRefPubMedPubMedCentral
29.
Chow, A., Zhou, W., et al. (2014). Macrophage immunomodulation by breast cancer-derived exosomes requires toll-like receptor 2-mediated activation of NF-kappaB. Scientific Reports , 4, 5750.CrossRefPubMedPubMedCentral
30.
Yu, S., Liu, C., et al. (2007). Tumor exosomes inhibit differentiation of bone marrow dendritic cells. Journal of Immunology , 178(11), 6867–6875.CrossRef
31.
Clayton, A., Al-Taei, S., et al. (2011). Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. Journal of Immunology , 187(2), 676–683.CrossRef
32.
Liu, C., Yu, S., et al. (2006). Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. Journal of Immunology , 176(3), 1375–1385.CrossRef
33.
Kosaka, N., Iguchi, H., et al. (2013). Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. The Journal of Biological Chemistry , 288(15), 10849–10859.CrossRefPubMedPubMedCentral
34.
Cogolludo, A., Moreno, L., et al. (2009). Activation of neutral sphingomyelinase is involved in acute hypoxic pulmonary vasoconstriction. Cardiovascular Research , 82(2), 296–302.CrossRefPubMed
35.
36.
Wilson, W. R., & Hay, M. P. (2011). Targeting hypoxia in cancer therapy. Nature Reviews. Cancer , 11(6), 393–410.CrossRefPubMed
37.
Zhao, H., Yang, L., et al. (2016). Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. eLife , 5, e10250.PubMedPubMedCentral
38.
Wang, T., Gilkes, D. M., et al. (2014). Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis. Proceedings of the National Academy of Sciences of the United States of America , 111(31), E3234–E3242.CrossRefPubMedPubMedCentral
39.
Parolini, I., Federici, C., et al. (2009). Microenvironmental pH is a key factor for exosome traffic in tumor cells. The Journal of Biological Chemistry , 284(49), 34211–34222.CrossRefPubMedPubMedCentral
40.
Ban, J. J., Lee, M., et al. (2015). Low pH increases the yield of exosome isolation. Biochemical and Biophysical Research Communications , 461(1), 76–79.CrossRefPubMed
41.
Ostrowski, M., Carmo, N. B., et al. (2010). Rab27a and Rab27b control different steps of the exosome secretion pathway. Nature Cell Biology , 12(1), 19–30 sup pp 11-13.CrossRefPubMed
42.
Bobrie, A., Krumeich, S., et al. (2012). Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Research , 72(19), 4920–4930.CrossRefPubMed
43.
Hendrix, A., Sormunen, R., et al. (2013). Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. International Journal of Cancer , 133(4), 843–854.CrossRefPubMed
44.
Zhang, J. X., Huang, X. X., et al. (2012). Overexpression of the secretory small GTPase Rab27B in human breast cancer correlates closely with lymph node metastasis and predicts poor prognosis. Journal of Translational Medicine , 10, 242.CrossRefPubMedPubMedCentral
45.
Tauro, B. J., Mathias, R. A., et al. (2013b). Oncogenic H-ras reprograms Madin-Darby canine kidney (MDCK)cell-derived exosomal proteins following epithelial-mesenchymal transition. Molecular & Cellular Proteomics , 12(8), 2148–2159.
46.
Garnier, D., Magnus, N., et al. (2012). Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. The Journal of Biological Chemistry , 287(52), 43565–43572.CrossRefPubMedPubMedCentral
47.
Gopal, S. K., Greening, D. W., et al. (2016). Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells. Oncotarget , 7, 19709–19722.PubMedPubMedCentral
48.
Thompson, C. A., Purushothaman, A., et al. (2013). Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. The Journal of Biological Chemistry , 288(14), 10093–10099.CrossRefPubMedPubMedCentral
49.
Hendrix, A., Maynard, D., et al. (2010). Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. Journal of the National Cancer Institute , 102(12), 866–880.CrossRefPubMedPubMedCentral
50.
Peinado, H., Aleckovic, M., et al. (2012). Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature Medicine , 18(6), 883–891.CrossRefPubMedPubMedCentral
51.
Admyre, C., Johansson, S. M., et al. (2007). Exosomes with immune modulatory features are present in human breast milk. Journal of Immunology , 179(3), 1969–1978.CrossRef
52.
Bissell, M. J., & Hines, W. C. (2011). Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nature Medicine , 17(3), 320–329.CrossRefPubMedPubMedCentral
53.
Lim, P. K., Bliss, S. A., et al. (2011). Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Research , 71(5), 1550–1560.CrossRefPubMed
54.
Ono, M., Kosaka, N., et al. (2014). Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Science Signaling , 7(332), ra63.CrossRefPubMed
Metadata
Title
Cancer-derived extracellular vesicles: the ‘soil conditioner’ in breast cancer metastasis?
Authors
Andrew R. Chin
Shizhen Emily Wang
Publication date
01-12-2016
Publisher
Springer US
Published in
Cancer and Metastasis Reviews / Issue 4/2016
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-016-9639-8

Other articles of this Issue 4/2016

Cancer and Metastasis Reviews 4/2016 Go to the issue

OriginalPaper

Cell lineage determinants as regulators of breast cancer metastasis

OriginalPaper

Advances in decoding breast cancer brain metastasis

OriginalPaper

The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer

Announcement

Biography—Li Ma

EditorialNotes

Preface

OriginalPaper

Patient-derived xenograft (PDX) models in basic and translational breast cancer research
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits